Literature DB >> 7845682

Expression patterns of the novel receptor-like tyrosine kinase, DDR, in human breast tumours.

K T Barker1, J E Martindale, P J Mitchell, T Kamalati, M J Page, D J Phippard, T C Dale, B A Gusterson, M R Crompton.   

Abstract

Using a reverse transcriptase-polymerase chain reaction based differential screening procedure, we have identified the discoidin domain receptor as a protein tyrosine kinase that is expressed in lymph nodes containing breast tumour metastases. By Northern blotting and in situ hybridisation we have demonstrated the expression of the discoidin domain receptor in human primary breast tumour samples, metastasis-containing lymph nodes and a number of normal tissues. Direct comparison of malignant breast and adjacent normal epithelial tissue revealed over expression in the tumour cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7845682

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop.

Authors:  Pat P Ongusaha; Jong-il Kim; Li Fang; Tai W Wong; George D Yancopoulos; Stuart A Aaronson; Sam W Lee
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

2.  Mesenchymal Stem Cells Sense Three Dimensional Type I Collagen through Discoidin Domain Receptor 1.

Authors:  A W Lund; J P Stegemann; G E Plopper
Journal:  Open Stem Cell J       Date:  2009

Review 3.  Wnt5a as an effector of TGFβ in mammary development and cancer.

Authors:  Rosa Serra; Stephanie L Easter; Wen Jiang; Sarah E Baxley
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-18       Impact factor: 2.673

Review 4.  Discoidin domain receptor tyrosine kinases: new players in cancer progression.

Authors:  Rajeshwari R Valiathan; Marta Marco; Birgit Leitinger; Celina G Kleer; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

5.  DDR2 polymorphisms and mRNA expression in lung cancers of Japanese patients.

Authors:  Hidefumi Sasaki; Masayuki Shitara; Keisuke Yokota; Katsuhiro Okuda; Yu Hikosaka; Satoru Moriyama; Motoki Yano; Yoshitaka Fujii
Journal:  Oncol Lett       Date:  2012-04-18       Impact factor: 2.967

6.  Discoidin domain receptor 1: New star in cancer-targeted therapy and its complex role in breast carcinoma.

Authors:  Hui Jing; Jingyuan Song; Junnian Zheng
Journal:  Oncol Lett       Date:  2018-01-15       Impact factor: 2.967

7.  The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism.

Authors:  J P Labrador; V Azcoitia; J Tuckermann; C Lin; E Olaso; S Mañes; K Brückner; J L Goergen; G Lemke; G Yancopoulos; P Angel; C Martínez; R Klein
Journal:  EMBO Rep       Date:  2001-05       Impact factor: 8.807

8.  DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells.

Authors:  E Olaso; K Ikeda; F J Eng; L Xu; L H Wang; H C Lin; S L Friedman
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

9.  Antitumor activity of 7RH, a discoidin domain receptor 1 inhibitor, alone or in combination with dasatinib exhibits antitumor effects in nasopharyngeal carcinoma cells.

Authors:  Qiu-Ping Lu; Wen-Dan Chen; Jie-Ren Peng; Yao-Dong Xu; Qian Cai; Gong-Kan Feng; Ke Ding; Xiao-Feng Zhu; Zhong Guan
Journal:  Oncol Lett       Date:  2016-09-05       Impact factor: 2.967

10.  Design and Optimization of 3'-(Imidazo[1,2-a]pyrazin-3-yl)-[1,1'-biphenyl]-3-carboxamides as Selective DDR1 Inhibitors.

Authors:  Cheng Mo; Zhang Zhang; Yupeng Li; Minhao Huang; Jian Zou; Jinfeng Luo; Zheng-Chao Tu; Yong Xu; Xiaomei Ren; Ke Ding; Xiaoyun Lu
Journal:  ACS Med Chem Lett       Date:  2020-01-06       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.